Literature DB >> 8756183

The distribution and significance of CNS adrenoceptors examined with in situ hybridization.

A P Nicholas1, T Hökfelt, V A Pieribone.   

Abstract

Several of the established alpha 1-, alpha 2- and beta-adrenoceptors have now been isolated and cloned. The in situ hybridization method has been used to map the distribution of many of these adrenoceptors within cells of the CNS. These studies add complementary and new information to our knowledge of adrenoceptor localization provided previously by radioligand-mediated autoradiography. Neuronal cell groups containing one or more mRNAs for seven adrenoceptor subtypes throughout the rat CNS have been mapped. In the present review Anthony Nicholas, Tomas Hökfelt and Vincent Pieribone will examine these localizations and discuss the additional information these maps supply, as well as some implications for understanding central noradrenaline and adrenaline systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756183     DOI: 10.1016/0165-6147(96)10022-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  47 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

3.  Alpha-1 adrenergic receptors in the medial preoptic area are involved in the induction of sleep.

Authors:  Velayudhan Mohan Kumar; Ramalingam Vetrivelan; Hruda Nanda Mallick
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

4.  Formalin hindpaw injection induces changes in the [3H]prazosin binding to alpha1-adrenoceptors in specific regions of the mouse brain and spinal cord.

Authors:  I Nalepa; J Vetulani; V Borghi; M Kowalska; B Przewłocka; F Pavone
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

5.  Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.

Authors:  Benoit Forget; Carrie Wertheim; Paola Mascia; Abhiram Pushparaj; Steven R Goldberg; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

6.  Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.

Authors:  K Gyires; Z S Zádori; N Shujaa; M Al-Khrasani; B Pap; M M Mózes; P Mátyus
Journal:  Inflammopharmacology       Date:  2009-06-13       Impact factor: 4.473

7.  Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex.

Authors:  Y Kawaguchi; T Shindou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

8.  GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex.

Authors:  R Kaushal; B K Taylor; A B Jamal; L Zhang; F Ma; R Donahue; K N Westlund
Journal:  Neuroscience       Date:  2016-08-09       Impact factor: 3.590

9.  Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Authors:  Sudhirkumar U Yanpallewar; Kimberly Fernandes; Swananda V Marathe; Krishna C Vadodaria; Dhanisha Jhaveri; Karen Rommelfanger; Uma Ladiwala; Shanker Jha; Verena Muthig; Lutz Hein; Perry Bartlett; David Weinshenker; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

10.  Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists.

Authors:  Britta Hahn; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2004-07-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.